ARC
UTHR icon

Absolute Return Capital’s United Therapeutics UTHR Stock Holding History

Absolute Return Capital’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-21,681
Closed -$2.79M – 719
2014
Q3 		$2.79M Buy
+21,681
New +$2.24M 0.04% 387
2014
Q2 		– Sell
-23,285
Closed -$2.19M – 1381
2014
Q1 		$2.19M Buy
23,285
+1,578
+7% +$161K 0.03% 495
2013
Q4 		$2.46M Sell
21,707
-8,614
-28% -$777K 0.03% 479
2013
Q3 		$2.39M Sell
30,321
-46,407
-60% -$3.39M 0.03% 463
2013
Q2 		$5.05M Buy
+76,728
New +$4.94M 0.07% 338

Other funds holding UTHR

ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Absolute Return Capital's UTHR Position: Q4 2014 in Review

Absolute Return Capital sold out of United Therapeutics (UTHR) in Q4 2014, closing a stake of 21,681 shares — an estimated $2.79M sold.

Absolute Return Capital first reported a position in UTHR in Q2 2013 and held it in 5 quarters. The position peaked at $5.05M in Q2 2013. 334 funds tracked by Wall St. Rank hold UTHR as of Q4 2014.

  • Absolute Return Capital reported no remaining United Therapeutics position as of Q4 2014 after selling out during the quarter.
  • Absolute Return Capital sold 21,681 United Therapeutics shares in Q4 2014, an estimated $2.79M.
  • Absolute Return Capital first reported a position in United Therapeutics in Q2 2013 and held it in 5 quarters.
  • Absolute Return Capital's United Therapeutics position peaked at $5.05M in Q2 2013.
  • 334 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2014.

Based on Absolute Return Capital's 13F filing for Q4 2014, filed 17 Feb 2015.